Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 141, pseudogene (RNU1-141P) is a noncoding RNA pseudogene found in the human genome that resembles the U1 small nuclear RNA gene but includes sequence changes (mutations, deletions, or insertions) that disrupt functional expression[8][1][5][7]. The parental gene, U1 snRNA, plays an essential role in spliceosomal recognition of 5' splice sites during pre-mRNA splicing, and is a key component of the spliceosome[5][3]. In contrast, pseudogenes like RNU1-141P do not encode functional snRNA but may represent remnants of duplication or retrotransposition events. Recent research suggests some U1 snRNA pseudogenes may produce variant transcripts with regulatory roles in RNA processing or gene regulation, but these findings are limited to specific variants and not generalizable to RNU1-141P without direct experimental evidence[5][4]. Therefore, RNU1-141P is generally regarded as genomically silent, with no current therapeutic, diagnostic, or druggable relevance. It serves primarily as an annotation in genomic studies and gene family analyses, and is not a functional protein, enzyme, receptor, transporter, or transcription factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 141, pseudogene (RNU1-141P).